These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 3561773)

  • 41. Peripherally induced oromandibular dystonia.
    Sankhla C; Lai EC; Jankovic J
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):722-8. PubMed ID: 9810945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin A in blepharospasm and hemifacial spasm.
    Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
    J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [First use of botulinum toxin type B in ENT patients with secondary therapy failure of botulinum toxin type A].
    Guntinas-Lichius O
    HNO; 2004 Jan; 52(1):53-6. PubMed ID: 14740116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.
    Benninger MS; Gardner G; Grywalski C
    Arch Otolaryngol Head Neck Surg; 2001 Sep; 127(9):1083-5. PubMed ID: 11556856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Spasmodic dysphonia in course of Meige's syndrome--case report].
    Zalesska-Krecicka M; Morawska-Kochman M; Wierzbicka E; Skrzypek A; Krecicki T
    Otolaryngol Pol; 2006; 60(5):779-81. PubMed ID: 17263254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of dystonias].
    Marion MH
    Presse Med; 1999 Feb; 28(6):312-5. PubMed ID: 10073178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Local injection treatment with botulinum toxin A in blepharospasm, Meige syndrome and hemifacial spasm. Observations in 106 patients].
    Ceballos-Baumann AO; Gasser T; Dengler R; Oertel WH
    Nervenarzt; 1990 Oct; 61(10):604-10. PubMed ID: 2274092
    [No Abstract]   [Full Text] [Related]  

  • 48. Altered functional connectivity in blepharospasm/orofacial dystonia.
    Jochim A; Li Y; Gora-Stahlberg G; Mantel T; Berndt M; Castrop F; Dresel C; Haslinger B
    Brain Behav; 2018 Jan; 8(1):e00894. PubMed ID: 29568690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A survey about the accessibility to botulinum toxin therapy for dystonia].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review.
    Watts C; Nye C; Whurr R
    Clin Rehabil; 2006 Feb; 20(2):112-22. PubMed ID: 16541931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum A toxin injection. Failures in clinical practice and a biomechanical system for the study of toxin-induced paralysis.
    Holds JB; Fogg SG; Anderson RL
    Ophthalmic Plast Reconstr Surg; 1990; 6(4):252-9. PubMed ID: 2271481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute pharmacologic tests in cranial dystonia.
    Giménez-Roldán S; Mateo D; Orbe M; Muñoz-Blanco JL; Hípola D
    Adv Neurol; 1988; 49():451-66. PubMed ID: 3344636
    [No Abstract]   [Full Text] [Related]  

  • 53. [Experience with botulinum toxin treatment of facial-cervical dystonias and hemifacial spasm].
    Erbguth F; Claus D; Neundörfer B
    Nervenarzt; 1990 Oct; 61(10):611-4. PubMed ID: 2274093
    [No Abstract]   [Full Text] [Related]  

  • 54. Botulinum toxin.
    Consens Statement; 1990 Nov 12-14; 8(8):1-20. PubMed ID: 2098181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The botulinum toxins in the treatment of cervical dystonia.
    Brashear A
    Semin Neurol; 2001; 21(1):85-90. PubMed ID: 11346029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of spasmodic dysphonia with botulinum toxin].
    Vilkman E; Laurikainen E; Marttila R
    Duodecim; 1995; 111(16):1546-51. PubMed ID: 9273263
    [No Abstract]   [Full Text] [Related]  

  • 57. [Oromandibular dystonia and botulinum toxins].
    Van Durme B; Loeb I; Van Reck J
    Acta Stomatol Belg; 1996 Mar; 93(1):37-41. PubMed ID: 9005716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical experience with patients with spasmodic dysphonia and primary Meige syndrome.
    Pedrero-Escalas MF; García-López I; Santiago-Pérez S; Vivancos F; Gavilán J
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(1):1-5. PubMed ID: 29716720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin.
    Brin MF; Blitzer A; Stewart C
    Adv Neurol; 1998; 78():237-52. PubMed ID: 9750921
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical application of botulinum toxin].
    Grandas F
    Neurologia; 1995; 10(6):224-33. PubMed ID: 7546812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.